Ra Capital Management, L.P. Entera Bio Ltd. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.05 $893,203 - $1.88 Million	-1,786,406 Reduced 85.79%	295,966 $216,000
Q3 2022 Nov 14, 2022	SELL	$0.07 - $1.98 $18,943 - $535,843	-270,628 Reduced 11.5%	2,082,372 $2.17 Million
Q2 2021 Aug 16, 2021	BUY	$2.92 - $6.5 $6.87 Million - $15.3 Million	2,353,000 New	2,353,000 $14.1 Million

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $60.2M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.